Advancing Peptide Science 

Explore Research Materials The peptide industry was shaken recently when Eli Lilly filed lawsuits against several companies accused of selling products purported to contain Retatrutide, the company's highly anticipated investigational obesity and diabetes drug. Retatrutide has generated significant attention because of promising clinical trial results, but it has not yet received FDA approval for human use. According to Lilly, the lawsuits target companies that are allegedly

Explore Research Materials Peptide research has become one of the most exciting areas in modern biomedical science. Over the last decade, researchers have expanded our understanding of how small chains of amino acids can influence healing, metabolism, cellular communication, and disease treatment. While many studies are still ongoing, several areas of peptide research have had a significant impact on the scientific community and continue to shape future investigations. One of

Presented by Bluestar Biological Research Explore Research Materials Ipamorelin is a synthetic peptide that has attracted significant interest in scientific research due to its role as a selective growth hormone secretagogue. Researchers have studied ipamorelin for its ability to stimulate the release of growth hormone through activation of the growth hormone secretagogue receptor (GHS-R1a), often called the ghrelin receptor. Unlike some earlier compounds in the same category

The healthcare industry is experiencing a wave of innovation, and one of the most exciting areas of research involves peptides. These small chains of amino acids, often described as the building blocks of proteins, are attracting significant attention from scientists, physicians, and biotechnology companies for their potential to transform how diseases are treated and managed. Unlike many traditional medications, peptides can be designed to interact with the body in highly ta

GHK-Cu, short for glycyl-L-histidyl-L-lysine copper complex, is a naturally occurring peptide found in the human body. First identified in human plasma in the 1970s, this small molecule has attracted decades of research interest due to its apparent role in tissue repair, skin regeneration, and wound healing. Studies suggest that GHK-Cu levels decline with age, prompting researchers to explore its potential applications in healthy aging and regenerative medicine. One of the mo